Concepedia

Lu‐hai Yu

LY

Statistics

Publications

7

Citations

95

H-Index

7

Active since

2020

Affiliations

People's Hospital of Xinjiang Uygur Autonomous Region(Current)

Kai Biotech (South Korea)

Lu‐hai Yu is an author at People's Hospital of Xinjiang Uygur Autonomous Region specializing in medicine, pharmacogenetics, and pharmacogenomics.

Publications per year

2020–2022

7

Publications

7

Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China

Ting Zhao, Hongjian Li, Long Ma et al. · Epilepsy & Behavior · 2021 · 23 citations

, , +10

Impact of ABCB1 Polymorphism on Levetiracetam Serum Concentrations in Epileptic Uygur Children in China

Ting Zhao, Jing Yu, Tingting Wang et al. · Therapeutic Drug Monitoring · 2020 · 19 citations · Full text

, , +17

Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study

Lu‐hai Yu, Ting-ting Wang, Huidong Bai et al. · BMC Cardiovascular Disorders · 2021 · 11 citations · Full text

, , +17

Impact of ABCB1 Polymorphisms on Lacosamide Serum Concentrations in Uygur Pediatric Patients With Epilepsy in China

Ting Zhao, Hongjian Li, Jie Feng et al. · Therapeutic Drug Monitoring · 2021 · 11 citations · Full text

, , +17

Impact of ABCC2 1249G>A and −24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China

Ting Zhao, Hongjian Li, Huilan Zhang et al. · Therapeutic Drug Monitoring · 2022 · 11 citations · Full text

, , +17

1–5 of 7